Berry Genomics Co.,Ltd (SHE:000710)
China · Delayed Price · Currency is CNY 12.81
-0.19 (-1.46%)
Sep 26, 2025, 3:04 PM CST
Berry Genomics Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -228.93 | -192.43 | -427.2 | -248.93 | -110.82 | 210.67 | Upgrade |
Depreciation & Amortization | 83.31 | 91.05 | 113.94 | 102.72 | 106.4 | 76.9 | Upgrade |
Other Amortization | 12.63 | 9.31 | 8.91 | 12.56 | 13.83 | 13.41 | Upgrade |
Loss (Gain) From Sale of Assets | -1.7 | -1.74 | 0.01 | 0.35 | -0.26 | 0.45 | Upgrade |
Asset Writedown & Restructuring Costs | 0.81 | 0.66 | 159.38 | 0.07 | 5.16 | 0.02 | Upgrade |
Loss (Gain) From Sale of Investments | 31.38 | 40.16 | 82.67 | 144.31 | 49.13 | -41.4 | Upgrade |
Provision & Write-off of Bad Debts | 128.82 | 130.68 | 162.77 | 98 | 53.6 | 31.6 | Upgrade |
Other Operating Activities | 15.86 | 19.35 | 21.47 | 5.54 | 31.98 | 23.54 | Upgrade |
Change in Accounts Receivable | 148.61 | -16.69 | 83.22 | -24.6 | -134.88 | -295.23 | Upgrade |
Change in Inventory | 8.76 | 31.95 | 0.89 | 6.85 | -57.53 | 20.28 | Upgrade |
Change in Accounts Payable | -164.44 | -30.3 | -38.2 | -88.03 | 152.02 | 105.93 | Upgrade |
Change in Other Net Operating Assets | 0.63 | 0.63 | -11.26 | 50.74 | 22.42 | 6.97 | Upgrade |
Operating Cash Flow | 42.87 | 87.97 | 111.01 | 21.18 | 94.03 | 161.31 | Upgrade |
Operating Cash Flow Growth | -67.09% | -20.75% | 424.14% | -77.48% | -41.71% | 31.09% | Upgrade |
Capital Expenditures | -71.61 | -56.75 | -55.1 | -73.31 | -336.69 | -112.55 | Upgrade |
Sale of Property, Plant & Equipment | 136.76 | 421.04 | 0.13 | 0.09 | 0.43 | 0.03 | Upgrade |
Divestitures | - | - | - | 1.71 | - | 190.39 | Upgrade |
Investment in Securities | -15.7 | -171.5 | 0.6 | 20.22 | -11.21 | -0.65 | Upgrade |
Other Investing Activities | 24.66 | -2.36 | 7 | 1.87 | - | 1.75 | Upgrade |
Investing Cash Flow | 74.11 | 190.43 | -47.37 | -49.42 | -347.47 | 78.97 | Upgrade |
Long-Term Debt Issued | - | 123.3 | 212.43 | 286.27 | 207.87 | 404.05 | Upgrade |
Total Debt Issued | 172.56 | 123.3 | 212.43 | 286.27 | 207.87 | 404.05 | Upgrade |
Long-Term Debt Repaid | - | -353.54 | -264.22 | -339.28 | -199.05 | -239.35 | Upgrade |
Total Debt Repaid | -212.43 | -353.54 | -264.22 | -339.28 | -199.05 | -239.35 | Upgrade |
Net Debt Issued (Repaid) | -39.87 | -230.24 | -51.79 | -53.01 | 8.82 | 164.71 | Upgrade |
Issuance of Common Stock | - | - | - | - | 56.46 | - | Upgrade |
Repurchase of Common Stock | - | - | - | - | - | -150.12 | Upgrade |
Common Dividends Paid | -4.45 | -8.69 | -15.5 | -28.29 | -9.59 | -29.21 | Upgrade |
Other Financing Activities | 1.09 | 1.09 | - | - | -10.85 | -1 | Upgrade |
Financing Cash Flow | -43.23 | -237.85 | -67.29 | -81.3 | 44.84 | -15.62 | Upgrade |
Foreign Exchange Rate Adjustments | -0.96 | 1.63 | 1.5 | 11.19 | -2.67 | -6.68 | Upgrade |
Net Cash Flow | 72.79 | 42.18 | -2.15 | -98.35 | -211.27 | 217.97 | Upgrade |
Free Cash Flow | -28.74 | 31.22 | 55.91 | -52.13 | -242.66 | 48.76 | Upgrade |
Free Cash Flow Growth | - | -44.16% | - | - | - | - | Upgrade |
Free Cash Flow Margin | -2.95% | 2.90% | 4.86% | -3.81% | -17.06% | 3.17% | Upgrade |
Free Cash Flow Per Share | -0.08 | 0.09 | 0.16 | -0.17 | -0.68 | 0.14 | Upgrade |
Cash Income Tax Paid | 38.45 | 63.58 | 46.39 | -3.27 | 71.81 | 65.71 | Upgrade |
Levered Free Cash Flow | -285.74 | 16.38 | 206.97 | 18.73 | -210.42 | 115.99 | Upgrade |
Unlevered Free Cash Flow | -280.15 | 22.52 | 217.19 | 29.75 | -197.73 | 125.57 | Upgrade |
Change in Working Capital | 0.69 | -9.07 | -10.95 | -93.45 | -54.99 | -153.86 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.